Accéder au contenu
Merck

Stiffness and adhesivity control aortic valve interstitial cell behavior within hyaluronic acid based hydrogels.

Acta biomaterialia (2013-05-08)
Bin Duan, Laura A Hockaday, Edi Kapetanovic, Kevin H Kang, Jonathan T Butcher
RÉSUMÉ

Bioactive and biodegradable hydrogels that mimic the extracellular matrix and regulate valve interstitial cells (VIC) behavior are of great interest as three-dimensional (3-D) model systems for understanding mechanisms of valvular heart disease pathogenesis in vitro and the basis for regenerative templates for tissue engineering. However, the role of stiffness and adhesivity of hydrogels in VIC behavior remains poorly understood. This study reports the synthesis of methacrylated hyaluronic acid (Me-HA) and oxidized and methacrylated hyaluronic acid, and the subsequent development of hybrid hydrogels based on modified HA and methacrylated gelatin (Me-Gel) for VIC encapsulation. The mechanical stiffness and swelling ratio of the hydrogels were tunable with the molecular weight of the HA and the concentration/composition of the precursor solution. The encapsulated VIC in pure HA hydrogels with lower mechanical stiffness showed a more spreading morphology compared to their stiffer counterparts and dramatically up-regulated alpha smooth muscle actin expression, indicating more activated myofibroblast properties. The addition of Me-Gel in Me-HA facilitated cell spreading, proliferation and VIC migration from encapsulated spheroids and better maintained the VIC fibroblastic phenotype. The VIC phenotype transition during migration from encapsulated spheroids in both Me-HA and Me-HA/Me-Gel hydrogel matrixes was also observed. These findings are important for the rational design of hydrogels for controlling the VIC morphology, and for regulating the VIC phenotype and function. The Me-HA/Me-Gel hybrid hydrogels accommodated with VIC are promising as valve tissue engineering scaffolds and 3-D models for understanding valvular pathobiology.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Hyaluronic acid methacrylate, Degree of substitution: 10% - 30%, Mw 170,000-250,000
Sigma-Aldrich
Hyaluronic acid methacrylate, average degree of substitution 35%, average Mw 55000
Sigma-Aldrich
Hyaluronic acid methacrylate, average degree of substitution 35%, average Mw 175000
Sigma-Aldrich
Hyaluronic acid methacrylate, Low Viscosity, Low Endotoxin, 0.2 um sterile filtered, 0.2 μm, sterile-filtered